View Article

Abstract

In situ gel refers to a gel that forms when a solution is placed in the eye. The solution undergoes a transformation, typically from a liquid to a gel, in response to environmental conditions (like temperature, pH, or ionic strength). This helps the drug stay in place longer, improving its effectiveness by allowing for sustained release. Antibacterial ophthalmic. This means the formulation is designed for the eye and contains antibacterial agents that target eye infections. These agents are usually intended to treat or prevent bacterial infections like conjunctivitis or corneal ulcers. Such formulations are typically designed to offer controlled drug release, which can improve patient compliance and reduce side effects compared to traditional eye drops. The gel helps the drug remain in contact with the ocular surface for an extended period, while the antibacterial properties target pathogens that may cause infections.

Keywords

Eye, In situ gel , pH triggered in situ gelation, Temperature dependent in situ gelatin

Introduction

In ophthalmic care, bacterial infections of the eye, such as conjunctivitis or keratitis, require effective and targeted treatment. Traditional eye drops and ointments often fail to provide sustained drug release, resulting in suboptimal therapeutic outcomes. Improved Drug Retention is an instillation into the eye, the gel undergoes a phase transition, increasing its viscosity and allowing for prolonged contact time on the ocular surface. This leads to better drug retention and enhanced bioavailability compared to liquid formulations. Sustained Release is the in situ gels can be designed to release the antimicrobial agents slowly over time, ensuring a steady concentration of the drug at the infection site, reducing the frequency of administration and improving patient compliance. Targeted Delivery is the gel formulation can be tailored to deliver antibacterial agents directly to the site of infection, minimizing systemic side effects and improving the effectiveness of the treatment. Minimized Irritation in which  Unlike conventional eye drops that may cause irritation due to their frequent application or preservatives, in situ gels are often formulated to be gentle on the delicate ocular tissues, reducing irritation and enhancing patient comfort.

Fig No.1 : Anatomy of the eye(3)

ADVANTAGS OF IN SITU GEL(4)(5)

  1. To provide sustained and controlled drug delivery.
  2. To increase the ocular bioavailability of drug by increasing the corneal contact    time.
  3. Drug effect is prolonged hence frequent instillation of drug is not required.
  4. For patient compliance and enhance therapeutic performance of drug.

DISADVANTAGES OF IN SITU GEL

  1. May not reach deeper eye tissues effectively.
  2. Can cause eye discomfort or allergic reactions.
  3. Environmental factors can affect gel formation.
  4. May require frequent application.
  5. Can cause blurring or discomfort if too thick or thin.
  6. Difficult to produce stable formulations.

IDEAL CHARACTERISTICS OF IN SITU GEL(4)(6)

  1. It should not irritate or harm the sensitive eye tissues.
  2. The gel should stay on the eye longer for better drug absorption.
  3. It should release the antibacterial medicine slowly over time, reducing the need for frequent use.
  4. The gel should help the medicine get absorbed well into the eye.
  5. It should change into a gel when applied to the eye, helping it stay in place.

DISEASE OF EYE(1)

Eye diseases can affect different parts of the eye and can cause a range of symptoms, from redness and irritation to pain and vision problemsConjunctivitis is inflammation of the thin layer of tissue covering the white part of the eye. It’s usually caused by a bacterial or viral infection and causes redness, itching, and discharge. It’s highly contagious. The inflammation of the eyelids, often due to bacterial infections, causing redness, swelling, and crusting around the eyelashes. It can lead to irritation and discomfort. This is an  infection of the cornea, the clear front part of the eye. Bacterial keratitis can cause severe pain, blurred vision, sensitivity to light, and eye redness. It’s often seen in people who wear contact lenses Such infection occurs due to when you live in polluted air , moving in polluted air during road work cement particles and dust particles get into the eye and causes an antibacterial infection.

Fungal eye infection are extremely rare but they causes blindness the most common way to develop a fungal eye infection is as a result of eye injury. Particularly if the injury was caused by plant material such as stick or thorn.

CLASSIFICATION OF OPHTHALMIC IN SITU GEL(7)(5)

They are classified according to the natural polymer and synthetic polymers soluble, Insoluble are classified as follows:

NATURAL POLYMER

Natural polymers are derived from natural sources such as plants, animals, or microorganisms. They are often preferred in ophthalmic drug delivery systems like in situ gels due to their biocompatibility, biodegradability, and low toxicity. They can also be chemically modified to optimize the release profiles of drugs. They polymers are often chosen for their ability to form gels under specific conditions (e.g., pH, temperature, or ionic strength), enabling controlled drug release, enhanced ocular retention, and improved patient compliance. Their mucoadhesive properties further contribute to prolonged contact time with the ocular surface, thereby increasing drug bioavailability.

Synthetic polymers

Synthetic polymers are artificially synthesized macromolecules that are engineered through polymerization processes to achieve specific structural, chemical, and physical properties. These polymers offer a high degree of control over their molecular weight, architecture, and functionality, making them highly versatile in various applications, including drug delivery systems. In ophthalmic formulations, synthetic polymers are utilized to create in situ gel systems that provide controlled or sustained release of therapeutic agents, thereby improving drug bioavailability and enhancing patient compliance.

METHODS OF IN SITU GEL(6)(5)

  1. Thermally Trigged System

Temperature-sensitive hydrogels are probably the most commonly studied class of environment-sensitive polymer systems in drug delivery research. The use of biomaterial whose transitions from ‘sol to gel’ is triggered by increase in temperature is an attractive way to approach in-situ formation. The ideal critical temperature range for such system is ambient and physiologic temperature and no external source other than that of body heat is required to trigger gelation. A useful system should be endurable to account for small differences in local temperature, such as it might be encountered in appendages in the oral cavity

  1. pH Triggered Systems :

The second approach of in situ gel formation is based on Change in pH. Certain polymers such as PAA (Carbopol®, carbomer) or its derivatives, polyvinylacetal diethylaminoacetate (AEA), Mixtures of poly (methacrylic acid) (PMA) and poly (ethylene glycol) (PEG) shows change from sol to gel with change of pH. Swelling of hydrogel increases as the external pH increases in the case of weakly acidic (anionic) groups, but decreases if polymer contains weakly basic (cationic) groups.

  1.  Temperature Triggered system

Temperature is the most widely used stimulus in environmentally responsive polymer systems. The change of temperature is not only relatively easy to control, but also easily applicable both in vitro and in vivo. In this system, gelling of the solution is triggered by change in temperature, thus sustaining the drug release. These hydrogels are liquid at room temperature (20–25 °C) and undergo gelation when in contact with body fluids (35– 37 °C), due to an increase in temperature. The use of biomaterial whose transitions from sol-gel is triggered by increase in temperature is an attractive way to approach in situ formation. The polymers which show temperature induced gelation are Poloxamer or pluronics, cellulose derivatives (methyl cellulose, HPMC, ethyl (hydroxyl ethyl) cellulose (EHEC) and xyloglucan etc.

Table No.1: Excipient of in situ gel(8)

Sr No.

Exipients

Activity

1

API

Antibiotics

2

Sodium Alginate

Polymer

3

HPMC

polymer

4

Water

solvent

Preparation– of In Situ gel:(8)

Evaluation test of IN SITU Gel:(9)(10)

  1. Clarity

Clarity test was observed by visual inspection under a good light, viewed against a black and white background, with the contents set in motion with a swirling action. Also it was observed for formation of turbidity or any unwanted particles dispersed in the solution.

  1. Gelling capacity

The gelling capacity of the prepared formulation was de termined by placing a drop of the formulation in a beaker containing 50 ml of freshly prepared concentrated calcium chloride solution and was visually observed for gelling ti

  1. Rheological studies

The primitive ophthalmic solution, suspension, and ointment dosage forms are clearly no longer sufficient to combat these diseases, and current research and development efforts to design better therapeutic systems are the primary focus of this research work. The aim of the present investigation is to formulate an in situ gel and from our prior knowledge we know that gels show thixotropic behaviour, so rheological studies are to be performed.

  1. Measurement of pH

Each formulated batch, pH was measured using pH metre which was previously calibrated using standard buffers of pH 4 and pH 7 as per the established procedure.

  1. Drug content

1 ml of the developed formulation was dissolved in 100 ml phosphate buffer (pH¼7.4) followed by spectrophotometrically estimation of the aliquot to determine drug concentration.

  1. In vitro dissolution studies

Dissolution studies of samples were performed using Franz diffusion apparatus and phosphate buffer (pH¼7.4) as a dissoluation medium. Phosphate buffer with pH 7.4 will simulate the la chrymal fluid . The temperature was maintained at 3770.5 °C with the speed of rotation maintained at 100 rpm. The samples were withdrawn at various time intervals and analysed spectro photometrically for the drug content   

CONCLUSION :

In situ gel was successfully formulated as in situ gel forming eye drops using sodium alginate and HPMC. The mixture can be used as an in situ gelling vehicle to enhance ocular bioavailability and patient compliance. Physicochemical characterization and in vitro drug release studies indicated that the developed formulation (IG 3) may prove to be a viable alternative to conventional eye drops and ointment in terms of ease of administration with added benefits of sustained drug release which may ultimately result into improved.

REFERENCES

  1. Wasim K, Khadkutkar VK, Dudhamal SS. REVIEW ON OCULAR INSERTS: AN EVOLUTIONARY TREND FOR TARGETED DRUG DELIVERY [Internet]. Vol. 9, Certified Journal ? Vijayananda et al. European Journal of Pharmaceutical and Medical Research. 2022. Available from: www.ejpmr.com
  2. Journals H, Article R. A Review on Concept of In Situ Gel and Its Applications. 2020;(4).
  3. Meshram S, Thorat S. Review Article Ocular in Situ Gels: Development, Evaluation and Advancements. Sch Acad J Pharm [Internet]. 2022;4(7):340–6. Available from: www.saspublisher.com
  4. Saini R, Saini S, Singh G, Banerjee A. IN SITU GELS- A NEW TRENDS IN OPHTHALMIC DRUG DELIVERY SYSTEMS. Int J Pharma Sci Res.
  5. Garge L Saudagar R, Ph O. Ophthalmic pH Sensitive In-Situ Gel: A Review. Sensitive In-Situ Gel A Rev J Drug Deliv Ther [Internet]. 2019;9(s):300. Available from: http://jddtonline.info
  6. Article O. Effect of Vitex trifolia Linn and Solanum nigrum Linn on oxidative. 2017;269–75.
  7. Patil PR, Shaikh SS, Shivsharan KJ, Shahi SR. IN SITU GEL: A NOVEL DRUG DELIVERY SYSTEM. Indo Am J Pharm Res [Internet]. 2014; Available from: www.iajpr.com
  8. Makwana SB, Patel VA, Parmar SJ. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci. 2016;6:1–6.
  9. VYAS U, GEHALOT N, et al. a Review on in Situ Gelling System for Ophthalmic Drug Delivery. Curr Res Pharm Sci. 2022;11(4):98–106.
  10. Khan J, Khan A, Khan A, Khan D, Shaikh AH, Baig MS. In situ Gel: A Promising Ocular Drug Delivery System. Int J Adv Life Sci Res. 2024;7(3):65–77..

Reference

  1. Wasim K, Khadkutkar VK, Dudhamal SS. REVIEW ON OCULAR INSERTS: AN EVOLUTIONARY TREND FOR TARGETED DRUG DELIVERY [Internet]. Vol. 9, Certified Journal ? Vijayananda et al. European Journal of Pharmaceutical and Medical Research. 2022. Available from: www.ejpmr.com
  2. Journals H, Article R. A Review on Concept of In Situ Gel and Its Applications. 2020;(4).
  3. Meshram S, Thorat S. Review Article Ocular in Situ Gels: Development, Evaluation and Advancements. Sch Acad J Pharm [Internet]. 2022;4(7):340–6. Available from: www.saspublisher.com
  4. Saini R, Saini S, Singh G, Banerjee A. IN SITU GELS- A NEW TRENDS IN OPHTHALMIC DRUG DELIVERY SYSTEMS. Int J Pharma Sci Res.
  5. Garge L Saudagar R, Ph O. Ophthalmic pH Sensitive In-Situ Gel: A Review. Sensitive In-Situ Gel A Rev J Drug Deliv Ther [Internet]. 2019;9(s):300. Available from: http://jddtonline.info
  6. Article O. Effect of Vitex trifolia Linn and Solanum nigrum Linn on oxidative. 2017;269–75.
  7. Patil PR, Shaikh SS, Shivsharan KJ, Shahi SR. IN SITU GEL: A NOVEL DRUG DELIVERY SYSTEM. Indo Am J Pharm Res [Internet]. 2014; Available from: www.iajpr.com
  8. Makwana SB, Patel VA, Parmar SJ. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci. 2016;6:1–6.
  9. VYAS U, GEHALOT N, et al. a Review on in Situ Gelling System for Ophthalmic Drug Delivery. Curr Res Pharm Sci. 2022;11(4):98–106.
  10. Khan J, Khan A, Khan A, Khan D, Shaikh AH, Baig MS. In situ Gel: A Promising Ocular Drug Delivery System. Int J Adv Life Sci Res. 2024;7(3):65–77..

Photo
Dr. Shaikh Nasheer S.
Corresponding author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Photo
Anantwal Akshat
Co-author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Photo
Joshi Maharudra R.
Co-author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Photo
Kazi Wasim B.
Co-author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Photo
Limaye Akhilesh S.
Co-author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Photo
Rajput Amrapali V.
Co-author

Department of Pharmaceutics, Channabasweshwar Pharmacy Collage ( Degree) Latur, Maharashtra - 413512

Akshat Anantwal B., Joshi Maharudra R., Shaikh Nasheer S.*, Kazi Wasim B, Limaye Akhilesh S., Rajput Amrapali V., Ocular in Situ Gel: Development, Evaluation, and Advancement, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 4, 2466-2470. https://doi.org/10.5281/zenodo.15258490

More related articles
A Review Article on Ocular Drug Delivery Advances...
Bichkule Prajakta Sanjay , Ulka Mote , ...
Analytical Method Development And Validation Of Ch...
Nilesh G. Ahire, Nikhil Nikam, Sakshi Bhavsar, Rajendra Dighe, Ra...
Ocular Insert: Revolutionizing Drug Delivery Syste...
Aniket Kadam , Dr.Ravi Wanare, Rehan Beniwale , Akshay Jadhav, S...
Analytical Method Development And Validation Of Chloramphenicol Eye Ointment By ...
Nilesh G. Ahire, Nikhil Nikam, Sakshi Bhavsar, Rajendra Dighe, Rashid Azeez, Vinod A. Bairagi, ...
A Comprehensive Review on Dry Eye Syndrome...
Gajanan Sormare , Suraj Nirwan, Deep Selokar, Vrushabh Hete, Nishanth Awandekar, Milind Umekar, ...
Ocular Insert: Revolutionizing Drug Delivery System of Eye Care...
Aniket Kadam , Dr.Ravi Wanare, Rehan Beniwale , Akshay Jadhav, Sidharaj Solanke, Ram Gawande , ...
Related Articles
Emulgel For Keratoconjunctivitis Sicca...
Aditi Singh, Dr. Nakul Gupta, Dr. Md. Sarfaraz Alam, Kamal Singh Bani, Aanchal Dahiya, Preeti Bhunia...
Formulation And Development of Under Eye Cream...
Dhananjay Kashid , Ashwini Pundkar, Prachi Murkute, Dr. Santosh Payghan, ...
Ocular Insert: Revolutionizing Drug Delivery System of Eye Care...
Aniket Kadam , Dr.Ravi Wanare, Rehan Beniwale , Akshay Jadhav, Sidharaj Solanke, Ram Gawande , ...
Formulation And Evaluation of Herbal Eye Patches for Under-Eye Hydration and Dar...
Sejal Telang, Irshad Ahmad, Aishwarya Shrirao, Vaibhavi Shenmare, Sakshi Rewatkar, ...
A Review Article on Ocular Drug Delivery Advances...
Bichkule Prajakta Sanjay , Ulka Mote , ...
More related articles
A Review Article on Ocular Drug Delivery Advances...
Bichkule Prajakta Sanjay , Ulka Mote , ...
Analytical Method Development And Validation Of Chloramphenicol Eye Ointment By ...
Nilesh G. Ahire, Nikhil Nikam, Sakshi Bhavsar, Rajendra Dighe, Rashid Azeez, Vinod A. Bairagi, ...
Ocular Insert: Revolutionizing Drug Delivery System of Eye Care...
Aniket Kadam , Dr.Ravi Wanare, Rehan Beniwale , Akshay Jadhav, Sidharaj Solanke, Ram Gawande , ...
A Review Article on Ocular Drug Delivery Advances...
Bichkule Prajakta Sanjay , Ulka Mote , ...
Analytical Method Development And Validation Of Chloramphenicol Eye Ointment By ...
Nilesh G. Ahire, Nikhil Nikam, Sakshi Bhavsar, Rajendra Dighe, Rashid Azeez, Vinod A. Bairagi, ...
Ocular Insert: Revolutionizing Drug Delivery System of Eye Care...
Aniket Kadam , Dr.Ravi Wanare, Rehan Beniwale , Akshay Jadhav, Sidharaj Solanke, Ram Gawande , ...